Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.

Vinet J, van Zwam M, Dijkstra IM, Brouwer N, van Weering HR, Watts A, Meijer M, Fokkens MR, Kannan V, Verzijl D, Vischer HF, Smit MJ, Leurs R, Biber K, Boddeke HW.

Br J Pharmacol. 2013 Mar;168(6):1375-87. doi: 10.1111/bph.12042.

PMID:
23121557
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.

Watts AO, Verkaar F, van der Lee MM, Timmerman CA, Kuijer M, van Offenbeek J, van Lith LH, Smit MJ, Leurs R, Zaman GJ, Vischer HF.

J Biol Chem. 2013 Mar 8;288(10):7169-81. doi: 10.1074/jbc.M112.406108. Epub 2013 Jan 22.

PMID:
23341447
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.

Comerford I, Milasta S, Morrow V, Milligan G, Nibbs R.

Eur J Immunol. 2006 Jul;36(7):1904-16.

PMID:
16791897
[PubMed - indexed for MEDLINE]
4.

Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.

Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM.

Clin Cancer Res. 2009 May 1;15(9):2962-70. doi: 10.1158/1078-0432.CCR-08-2495. Epub 2009 Apr 21.

PMID:
19383822
[PubMed - indexed for MEDLINE]
Free Article
5.

Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.

Takatsuka S, Sekiguchi A, Tokunaga M, Fujimoto A, Chiba J.

J Pharmacol Toxicol Methods. 2011 May-Jun;63(3):250-7. doi: 10.1016/j.vascn.2010.12.003. Epub 2010 Dec 22.

PMID:
21184834
[PubMed - indexed for MEDLINE]
6.

The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.

Harata-Lee Y, Turvey ME, Brazzatti JA, Gregor CE, Brown MP, Smyth MJ, Comerford I, McColl SR.

Immunol Cell Biol. 2014 Nov;92(10):815-24. doi: 10.1038/icb.2014.58. Epub 2014 Jul 15.

PMID:
25027038
[PubMed - in process]
7.

CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).

Sauty A, Colvin RA, Wagner L, Rochat S, Spertini F, Luster AD.

J Immunol. 2001 Dec 15;167(12):7084-93.

PMID:
11739530
[PubMed - indexed for MEDLINE]
Free Article
8.

Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.

Meyer M, Hensbergen PJ, van der Raaij-Helmer EM, Brandacher G, Margreiter R, Heufler C, Koch F, Narumi S, Werner ER, Colvin R, Luster AD, Tensen CP, Werner-Felmayer G.

Eur J Immunol. 2001 Aug;31(8):2521-7.

PMID:
11500837
[PubMed - indexed for MEDLINE]
9.
10.

Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.

Catusse J, Leick M, Groch M, Clark DJ, Buchner MV, Zirlik K, Burger M.

Mol Cancer. 2010 Nov 22;9:297. doi: 10.1186/1476-4598-9-297.

PMID:
21092185
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.

Watts AO, van Lipzig MM, Jaeger WC, Seeber RM, van Zwam M, Vinet J, van der Lee MM, Siderius M, Zaman GJ, Boddeke HW, Smit MJ, Pfleger KD, Leurs R, Vischer HF.

Br J Pharmacol. 2013 Apr;168(7):1662-74. doi: 10.1111/bph.12064.

PMID:
23170857
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses.

Comerford I, Nibbs RJ, Litchfield W, Bunting M, Harata-Lee Y, Haylock-Jacobs S, Forrow S, Korner H, McColl SR.

Blood. 2010 Nov 18;116(20):4130-40. doi: 10.1182/blood-2010-01-264390. Epub 2010 Jun 18.

PMID:
20562329
[PubMed - indexed for MEDLINE]
Free Article
13.

Expression of CCX CKR in pulmonary sarcoidosis.

Kriegova E, Tsyrulnyk A, Arakelyan A, Mrazek F, Ordeltova M, Petzmann S, Zatloukal J, Kolek V, du Bois RM, Popper H, Petrek M.

Inflamm Res. 2006 Oct;55(10):441-5.

PMID:
17109071
[PubMed - indexed for MEDLINE]
14.

Regulation of chemotactic networks by 'atypical' receptors.

Comerford I, Litchfield W, Harata-Lee Y, Nibbs RJ, McColl SR.

Bioessays. 2007 Mar;29(3):237-47. Review.

PMID:
17295321
[PubMed - indexed for MEDLINE]
15.

Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

Yoshimura T, Oppenheim JJ.

Exp Cell Res. 2011 Mar 10;317(5):674-84. doi: 10.1016/j.yexcr.2010.10.023. Epub 2010 Nov 4. Review.

PMID:
21056554
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.

Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR.

J Exp Med. 1996 Jun 1;183(6):2437-48.

PMID:
8676064
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.

Cox MA, Jenh CH, Gonsiorek W, Fine J, Narula SK, Zavodny PJ, Hipkin RW.

Mol Pharmacol. 2001 Apr;59(4):707-15.

PMID:
11259614
[PubMed - indexed for MEDLINE]
Free Article
18.

Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Scholten DJ, Canals M, Wijtmans M, de Munnik S, Nguyen P, Verzijl D, de Esch IJ, Vischer HF, Smit MJ, Leurs R.

Br J Pharmacol. 2012 Jun;166(3):898-911. doi: 10.1111/j.1476-5381.2011.01648.x.

PMID:
21883151
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M.

Immunology. 2010 Apr;129(4):536-46. doi: 10.1111/j.1365-2567.2009.03209.x. Epub 2009 Dec 2.

PMID:
20002784
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.

Manousou P, Kolios G, Drygiannakis I, Pyrovolaki K, Bourikas L, Papadaki HA, Kouroumalis E.

J Gastroenterol Hepatol. 2008 Dec;23(12):1823-33. doi: 10.1111/j.1440-1746.2008.05486.x. Epub 2008 Aug 28.

PMID:
18761554
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk